New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
12:00 EDTCLRXCollabRx falls 7.4%
CollabRx is down 7.4%, or 26c, to $3.24
News For CLRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
06:33 EDTCLRXCollabRx and Medytox Solutions sign letter of intent for business combination
Subscribe for More Information
06:32 EDTCLRXCollabRx, Medytox sign non-binding LOI for possible business combination
Subscribe for More Information
January 20, 2015
16:07 EDTCLRXCollabRx receives non compliance letter from NASDAQ
CollabRx announced that it received a letter from the NASDAQ Listing Qualifications Staff indicating that, unless the Company timely requests a hearing before the NASDAQ Listing Qualifications Panel, the Company's securities would be delisted from The NASDAQ Capital Market due to the Company's non-compliance with NASDAQ Listing Rule 5550. The Company intends to timely request a hearing before the Panel, at which hearing the Company will present its plan to evidence compliance with the Rule, which requires the Company to maintain a minimum of $2.5M in stockholders' equity.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use